Optimal management of giant cell arteritis and polymyalgia rheumatica
Rodger CharltonCollege of Medicine, Swansea University, Wales, UKAbstract: Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are clinical diagnoses without "gold standard" serological or histological tests, excluding temporal artery biopsy for GCA. Further, other conditions may m...
Saved in:
Main Author: | Charlton R (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2012-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Baricitinib in polymyalgia rheumatica and giant cell arteritis: report of six cases
by: D. Camellino, et al.
Published: (2024) -
Giant cell arteritis and polymyalgia rheumatica as first manifestation of typical pulmonary carcinoid tumor
by: T. Aguiar, et al.
Published: (2016) -
Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey
by: Pierre-André Jarrot, et al.
Published: (2024) -
Polymyalgia rheumatica (PMR)
by: Jan Tore Gran, et al.
Published: (2008) -
Imaging in polymyalgia rheumatica
by: N. Possemato, et al.
Published: (2018)